Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is ongoing in Germany, in Poland, and in Spain. It is testing Intranasal BPL-003, with Open Label Extension, for treatment-resistant depression.
In Germany
This study is completed. It focuses on depression and currently lists study information in Germany.
In MunichThis study was terminated in the United Kingdom. It focuses on Bipolarity.
In United KingdomThis study was terminated in the United Kingdom. It is testing brief cognitive behavioural therapy for depression.
In United Kingdom
This study is ongoing in the United Kingdom. It is testing randomised Controlled Trial of Escitalopram and Nortriptyline compared with placebo and standard psychological care for depression.
In United KingdomThis study is ongoing in the Netherlands. It focuses on depression.
In NetherlandsThis study is ongoing in the United Kingdom. It focuses on Schizophrenia.
In United KingdomThis study is ongoing in the United Kingdom. It is testing lithium and quetiapine augmentation for treatment-resistant depression.
In United KingdomThis study is ongoing in the United Kingdom. It is testing IP2018 for Depression.
In United KingdomThis study is ongoing in the United Kingdom. It focuses on manic episodes in bipolarity.
In United KingdomThis study is ongoing in the United Kingdom. It is testing randomised, placebo controlled trial of psilocybin for treatment-resistant depression.
In United KingdomThis study is ongoing in the United Kingdom and . It focuses on depression.
In United KingdomHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.